Verastem, Inc. (NASDAQ: VSTM) is capturing the attention of investors with its promising potential upside of 164.73%, according to recent analyst ratings. This biopharmaceutical company, headquartered..
Emergent BioSolutions Inc. (NYSE: EBS), renowned for its pivotal role in public health threat preparedness, is garnering attention from investors due to its notable 28.08% potential..
Rapport Therapeutics, Inc. (NASDAQ: RAPP), a promising player in the biotechnology sector, is attracting attention with its ambitious focus on developing transformational small molecule medicines for..
Standard BioTools Inc. (NASDAQ: LAB) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $476.86 million,..
MBX Biosciences, Inc. (MBX), a beacon of innovation in the healthcare sector, is capturing investor attention with its promising pipeline of precision peptide therapies. As a..
Investors eyeing the biotechnology sector may find Zevra Therapeutics, Inc. (NASDAQ: ZVRA) an intriguing proposition. This U.S.-based company, with a market capitalization of $470.65 million, is..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a clinical-stage biopharmaceutical company, has captured the attention of investors with its promising pipeline of cancer therapies. Specializing in developing treatments..
Castle Biosciences, Inc. (NASDAQ: CSTL), a dynamic player in the healthcare sector specializing in molecular diagnostics, is catching the attention of investors with its promising potential...
Oruka Therapeutics, Inc. (NASDAQ: ORKA), a clinical-stage biopharmaceutical company headquartered in Menlo Park, California, is capturing investors’ attention with a significant potential upside of 77.17%, according..
In the ever-evolving world of biotechnology, Precigen, Inc. (NASDAQ: PGEN) stands out as a compelling player, particularly with its ambitious focus on gene and cell therapies..
Abivax SA (ABVX), a Paris-based biotechnology firm, is capturing significant investor interest with its promising drug pipeline and a compelling 37.93% potential upside. While the company..
OrthoPediatrics Corp. (NASDAQ: KIDS) represents a unique player in the healthcare sector, specifically within the medical devices industry. This Indiana-based company is dedicated to addressing the..
Inventiva S.A. (IVA), a dynamic player in the biotechnology sector, is capturing investor attention with its cutting-edge pursuits in treating metabolic and rare diseases. Headquartered in..
Humacyte, Inc. (NASDAQ: HUMA), a trailblazer in the biotechnology sector, is making waves with its innovative approach to bioengineered human tissues. As the company pioneers advanced..
Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical firm, is currently catching the eye of investors with a compelling potential upside of 148.86%, according to recent..
Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company, has been making waves in the biotechnology sector with its innovative approach to developing small molecule precision..
For investors with an eye on the biotechnology sector, PureTech Health plc (NASDAQ: PRTC) presents a compelling case with its exceptional revenue growth metrics and diverse..
